Safety and efficacy of allogeneic natural killer cell immunotherapy on human immunodeficiency virus type 1 immunological non-responders: a brief report

BACKGROUND: Allogeneic natural killer (NK) cell immunotherapy is recognized as a promising anti-tumor strategy, but whether it plays a role in poor CD4 recovery among human immunodeficiency virus type 1 (HIV-1) infected patients is unknown. This study aimed to investigate the safety and effectivenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Huan, Wang, Yin, Sun, Hua-Li, Gao, Li-Ying, Cao, Yu, Zaongo, Silvere D., Zeng, Rong-Nan, Wu, Hao, Zhang, Ming-Jie, Ma, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717728/
https://www.ncbi.nlm.nih.gov/pubmed/33273328
http://dx.doi.org/10.1097/CM9.0000000000001189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7717728/
https://www.ncbi.nlm.nih.gov/pubmed/33273328
http://dx.doi.org/10.1097/CM9.0000000000001189

Ejemplares similares